These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8745167)

  • 1. Effects of tandospirone on second messenger systems and neurotransmitter release in the rat brain.
    Tanaka H; Tatsuno T; Shimizu H; Hirose A; Kumasaka Y; Nakamura M
    Gen Pharmacol; 1995 Dec; 26(8):1765-72. PubMed ID: 8745167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic mechanisms in anxiolytic effect of tandospirone in the Vogel conflict test.
    Shimizu H; Tatsuno T; Tanaka H; Hirose A; Araki Y; Nakamura M
    Jpn J Pharmacol; 1992 May; 59(1):105-12. PubMed ID: 1354771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission.
    Godbout R; Chaput Y; Blier P; de Montigny C
    Neuropharmacology; 1991 Jul; 30(7):679-90. PubMed ID: 1681446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic modulation of synaptic gamma-aminobutyric acid transmission by tandospirone in rat basolateral amygdala.
    Kishimoto K; Koyama S; Akaike N
    Eur J Pharmacol; 2000 Nov; 407(3):257-65. PubMed ID: 11068021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of tandospirone (SM-3997) interactions with neurotransmitter receptor binding sites.
    Hamik A; Oksenberg D; Fischette C; Peroutka SJ
    Biol Psychiatry; 1990 Jul; 28(2):99-109. PubMed ID: 1974152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat.
    Haj-Dahmane S; Jolas T; Laporte AM; Gozlan H; Farré AJ; Hamon M; Lanfumey L
    Eur J Pharmacol; 1994 Apr; 255(1-3):185-96. PubMed ID: 8026543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chronic treatments with tandospirone and imipramine on serotonin-mediated behavioral responses and monoamine receptors.
    Wieland S; Fischette CT; Lucki I
    Neuropharmacology; 1993 Jun; 32(6):561-73. PubMed ID: 8393153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--II. Effects of acute administration of 1-PP and long-term administration of tandospirone on noradrenergic neurotransmission.
    Blier P; Curet O; Chaput Y; de Montigny C
    Neuropharmacology; 1991 Jul; 30(7):691-701. PubMed ID: 1681447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
    Palego L; Giromella A; Marazziti D; Borsini F; Naccarato AG; Giannaccini G; Lucacchini A; Cassano GB; Mazzoni MR
    Brain Res; 1999 Jan; 816(1):165-74. PubMed ID: 9878719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tandospirone, a 5-HT1A agonistic anxiolytic agent, on haloperidol-induced catalepsy and forebrain Fos expression in mice.
    Ohno Y; Shimizu S; Imaki J
    J Pharmacol Sci; 2009 Apr; 109(4):593-9. PubMed ID: 19352073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoradiographic localization and pharmacological characterization of [3H]tandospirone binding sites in the rat brain.
    Tanaka H; Shimizu H; Kumasaka Y; Hirose A; Tatsuno T; Nakamura M
    Brain Res; 1991 Apr; 546(2):181-9. PubMed ID: 1648988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tandospirone stimulates prolactin secretion in the rat by an action at serotonin-1A receptors.
    Mulroney SE; Skudlarek C; Shemer A; Lumpkin MD; Kellar KJ
    J Pharmacol Exp Ther; 1994 Feb; 268(2):862-7. PubMed ID: 8113999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tandospirone suppresses impulsive action by possible blockade of the 5-HT1A receptor.
    Ohmura Y; Kumamoto H; Tsutsui-Kimura I; Minami M; Izumi T; Yoshida T; Yoshioka M
    J Pharmacol Sci; 2013; 122(2):84-92. PubMed ID: 23707971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandospirone, a 5-HT1A agonist, ameliorates movement disorder via non-dopaminergic systems in rats with unilateral 6-hydroxydopamine-generated lesions.
    Matsubara K; Shimizu K; Suno M; Ogawa K; Awaya T; Yamada T; Noda T; Satomi M; Ohtaki K; Chiba K; Tasaki Y; Shiono H
    Brain Res; 2006 Sep; 1112(1):126-33. PubMed ID: 16884702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1A receptor agonists induce anterograde amnesia in mice through a postsynaptic mechanism.
    Mendelson SD; Quartermain D; Francisco T; Shemer A
    Eur J Pharmacol; 1993 May; 236(2):177-82. PubMed ID: 8319749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic treatment with tandospirone, a serotonin 1A receptor partial agonist, inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior.
    Murata Y; Yanagihara Y; Mori M; Mine K; Enjoji M
    J Affect Disord; 2015 Jul; 180():1-9. PubMed ID: 25879718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonflict action of tandospirone in a modified Geller-Seifter conflict test in rats.
    Shimizu H; Kumasaka Y; Tanaka H; Hirose A; Nakamura M
    Jpn J Pharmacol; 1992 Mar; 58(3):283-9. PubMed ID: 1355147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the biochemical basis for the discriminative properties of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Rabin RA; Winter JC
    Eur J Pharmacol; 1993 Apr; 235(2-3):237-43. PubMed ID: 8508905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tandospirone activates neuroendocrine and ERK (MAP kinase) signaling pathways specifically through 5-HT1A receptor mechanisms in vivo.
    Sullivan NR; Crane JW; Damjanoska KJ; Carrasco GA; D'Souza DN; Garcia F; Van de Kar LD
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):18-26. PubMed ID: 15655673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.